Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Nov;62(11):992-1000.
doi: 10.1111/jsap.13421. Epub 2021 Oct 4.

Tolerability and outcome of palliative treatment for metastatic pulmonary carcinoma in cats

E Treggiari  1 , M A Pellin  2 , P Valenti  3 , K M Curran  4 , J F Borrego  5 , G Romanelli  1 , S L Mason  6   7 , A Taylor  8
Affiliations

Tolerability and outcome of palliative treatment for metastatic pulmonary carcinoma in cats

E Treggiari et al. J Small Anim Pract. 2021 Nov.

Abstract

Objectives: Pulmonary carcinoma is uncommon in cats and reporting of outcomes following medical treatment is limited, especially in presence of metastases. The aim of this study was to describe the outcome of cats affected by metastatic primary pulmonary carcinoma and to evaluate the tolerability of palliative treatment in this patient population.

Materials and methods: Medical records were searched for cats with a cytological or histopathological diagnosis of primary pulmonary carcinoma and evidence of metastatic disease. Cats were treated with antineoplastic agents, corticosteroids, non-steroidal anti-inflammatory drugs (NSAIDs) or received no systemic treatment. Cases in which thoracic CT was not performed, and those lacking definitive diagnosis by cytology or histopathology or receiving curative-intent surgery were excluded.

Results: Thirty-four cats were identified: 18 were treated with antineoplastic agents and 16 received corticosteroids, NSAIDs or no treatment. Presenting clinical signs included coughing (53%), tachypnoea (26%), gastrointestinal signs (35%) and lethargy (18%). CT scan identified metastases to the lung parenchyma in all cases and additional metastatic lesions in 10 of 34 (59%) cases; pleural effusion was detected in 11 cases (32%). The overall median survival time for all cats was 64 days [range 1-1352 days; 95% confidence interval (CI) 48-164]. Presence of respiratory signs at presentation was the only factor influencing survival in the multivariable analysis.

Clinical significance: Medical treatment was well tolerated and appeared to palliate clinical signs in cats with metastatic pulmonary carcinoma, albeit with a modest duration and short overall survival. The role and benefit of chemotherapy/antineoplastic agents versus conventional palliative drugs in this setting remains unclear.

PubMed Disclaimer

References

    1. Aarsvold, S., Reetz, J. A., Reichle, J. K., et al. (2015) Computed tomographic findings in 57 cats with primary pulmonary neoplasia. Veterinary Radiology & Ultrasound: The Official Journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association 56, 272-277
    1. Armbrust, L. J., Biller, D. S., Bamford, A., et al. (2012) Comparison of three-view thoracic radiography and computed tomography for detection of pulmonary nodules in dogs with neoplasia. Journal of the American Veterinary Medical Association 240, 1088-1094
    1. Barr, F., Gruffydd-Jones, T. J., Brown, P. J., et al. (1987) Primary lung tumours in the cat. Journal of Small Animal Practice 28, 1115-1125
    1. Beam, S. L., Rassnick, K. M., Moore, A. S., et al. (2003) An immunohistochemical study of cyclooxygenase-2 expression in various feline neoplasms. Veterinary Pathology 40, 496-500
    1. Biller, B. (2014) Metronomic chemotherapy in veterinary patients with cancer: rethinking the targets and strategies of chemotherapy. The Veterinary Clinics of North America Small Animal Practice 44, 817-829

LinkOut - more resources